EMA Set To Discuss Safety Of Ranitidine

Follows US Announcement That Zantac And Generics Must Be Withdrawn

 
• By Vibha Sharma
  
Nitrosodimethylamine
EMA Is Investigating The Safety Of Ranitidine Medicines • Source: Shutterstock

More from Regulation

More from Policy & Regulation